fda warning about semaglutide warns safety of 'off-brand' versions of Ozempic, Wegovy U.S. FDA finds no evidence

Examples of these include semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound)

doi: 10.1172/JCI112357 8 SnchezMLRodrguezFDCoveasR

He is currently pursuing his Ph.D

Senescence & Ageing Research Selected for experimental work focused on cellular senescence, stress-response pathways and ageing-related signalling

Weve been very interested in providing some policyrelevant evidence about what it would take to save money in the long run. Achieving cost neutrality would require the long-term healthcare savings to completely offset the cost of the drugs

Not everyone is recommended to take semaglutide as a weight management treatment